SJS Investment Consulting’s Tenet Healthcare THC Stock Holding History

SJS Investment Consulting’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.1K	Sell	70 -118	-63%	-$21.7K	﹤0.01%	965
2026 Q1	$35.5K	Sell	188 -65	-26%	-$13.7K	﹤0.01%	499
2025 Q4	$50.3K	Buy	253 +191	+308%	+$38.6K	0.01%	360
2025 Q3	$12.6K	Buy	62 +52	+520%	+$9.23K	﹤0.01%	589
2025 Q2	$1.76K	Sell	10 -7	-41%	-$1.05K	﹤0.01%	615
2025 Q1	$2.29K	Hold	17	–	–	﹤0.01%	670
2024 Q4	$2.15K	Sell	17 -4	-19%	-$595	﹤0.01%	673
2024 Q3	$3.49K	Hold	21	–	–	﹤0.01%	574
2024 Q2	$2.79K	Hold	21	–	–	﹤0.01%	590
2024 Q1	$2.21K	Hold	21	–	–	﹤0.01%	699
2023 Q4	$1.59K	Sell	21 -1	-5%	-$63	﹤0.01%	761
2023 Q3	$1.45K	Hold	22	–	–	﹤0.01%	770
2023 Q2	$1.79K	Buy	22 +1	+5%	+$71	﹤0.01%	646
2023 Q1	$1.25K	Buy	21 +6	+40%	+$334	﹤0.01%	794
2022 Q4	$732	Buy	15 +7	+88%	+$324	﹤0.01%	1083
2022 Q3	$0	Buy	+8	New	+$475	﹤0.01%	1539
2022 Q1	$0	Buy	+3	New	+$246	﹤0.01%	1313

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SJS Investment Consulting's THC Position: Q2 2026 in Review

SJS Investment Consulting reduced its Tenet Healthcare (THC) stake by 63% in Q2 2026, selling an estimated $21.7K and leaving 70 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

SJS Investment Consulting first reported a position in THC in Q1 2022 and has held it in 17 quarters since. The position peaked at $50.3K in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

SJS Investment Consulting held 70 shares of Tenet Healthcare worth $13.1K as of Q2 2026.
SJS Investment Consulting sold 118 Tenet Healthcare shares in Q2 2026, an estimated $21.7K.
Tenet Healthcare made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #965 holding.
SJS Investment Consulting first reported a position in Tenet Healthcare in Q1 2022 and has held it in 17 quarters since.
SJS Investment Consulting's Tenet Healthcare position peaked at $50.3K in Q4 2025.
681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.